These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epigenetic Alteration by DNA Methylation of ESR1, MYOD1 and hTERT Gene Promoters is Useful for Prediction of Response in Patients of Locally Advanced Invasive Cervical Carcinoma Treated by Chemoradiation. Sood S; Patel FD; Ghosh S; Arora A; Dhaliwal LK; Srinivasan R Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):720-7. PubMed ID: 26344356 [TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma. Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K; Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221 [TBL] [Abstract][Full Text] [Related]
4. Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines. Sood S; Srinivasan R Mol Cell Biochem; 2015 Jun; 404(1-2):181-91. PubMed ID: 25772483 [TBL] [Abstract][Full Text] [Related]
5. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population. Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185 [TBL] [Abstract][Full Text] [Related]
6. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer. Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000 [TBL] [Abstract][Full Text] [Related]
7. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer. Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246 [TBL] [Abstract][Full Text] [Related]
8. A COMPARATIVE ANALYSIS OF METHYLATION STATUS OF TUMOR SUPPRESSOR GENES IN PAIRED BIOPSY AND SERUM SAMPLES FROM CERVICAL CANCER PATIENTS AMONG NORTH INDIAN POPULATION. Jha AK; Sharma V; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J Genetika; 2016 Feb; 52(2):255-9. PubMed ID: 27215041 [TBL] [Abstract][Full Text] [Related]
9. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells. Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis. Yang WT; Zheng PS PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169 [TBL] [Abstract][Full Text] [Related]
12. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression. Iliopoulos D; Oikonomou P; Messinis I; Tsezou A Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524 [TBL] [Abstract][Full Text] [Related]
13. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast. Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821 [TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells. Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960 [TBL] [Abstract][Full Text] [Related]
15. Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer. Spitzwieser M; Holzweber E; Pfeiler G; Hacker S; Cichna-Markl M Breast Cancer Res; 2015 Sep; 17(1):125. PubMed ID: 26370119 [TBL] [Abstract][Full Text] [Related]
16. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945 [TBL] [Abstract][Full Text] [Related]
17. A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. Zambrano P; Segura-Pacheco B; Perez-Cardenas E; Cetina L; Revilla-Vazquez A; Taja-Chayeb L; Chavez-Blanco A; Angeles E; Cabrera G; Sandoval K; Trejo-Becerril C; Chanona-Vilchis J; Duenas-González A BMC Cancer; 2005 Apr; 5():44. PubMed ID: 15862127 [TBL] [Abstract][Full Text] [Related]
18. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma. Ye F; Zhang SF; Xie X; Lu WG Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347 [TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis. Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087 [TBL] [Abstract][Full Text] [Related]
20. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis. Huang J; Luo JY; Tan HZ PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]